Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of a monoclonal antibody therapy for advanced cancer has been completed, evaluating patients across several hematologic and solid tumor indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Precancerous and Nonmalignant Conditions
• Unspecified Adult Solid Tumor Protocol Specific

Drugs mentioned

• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: University of Arizona | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: COMPLETED